Epigenetics: A promising paradigm for better understanding and managing pain

Journal of Pain

Volumn 14, Issue 6, 2013, Pages 549-557

  Seo, Seungmae ^a   Grzenda, Adrienne ^a   Lomberk, Gwen ^a   Ou, Xiao Ming ^b   Cruciani, Ricardo A ^c   Urrutia, Raul ^a  

^a Center for Individualized Medicine   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

chromatin; DNA methylation; epigenetic; histone modification; opioid receptors; Pain; transcription factor

Indexed keywords

DNA; ENTINOSTAT; HISTONE; TRICHOSTATIN A; VORINOSTAT;

ANALGESIA; CENTROMERE; CHROMATIN STRUCTURE; CHROMOSOME SEGREGATION; DNA METHYLATION; EPIGENETICS; EUCHROMATIN; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE SILENCING; GENETIC TRANSCRIPTION; HETEROCHROMATIN; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; NOCICEPTION; NONHUMAN; NUCLEOSOME; PAIN; PHARMACOGENOMICS; PROMOTER REGION; REVIEW;

EPIGENESIS, GENETIC; HUMANS; PAIN; PAIN MANAGEMENT;

EID: 84878347814     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2013.01.772     Document Type: Review

References (89)

1. A. Beyer, T. Koch, H. Schroder, S. Schulz, and V. Hollt Effect of the a118g polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor J Neurochem 89 2004 553 560
2. C. Bond, K.S. LaForge, M. Tian, D. Melia, S. Zhang, L. Borg, J. Gong, J. Schluger, J.A. Strong, S.M. Leal, J.A. Tischfield, M.J. Kreek, and L. Yu Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction Proc Natl Acad Sci U S A 95 1998 9608 9613
3. C. Borner, V. Hollt, and J. Kraus Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene Mol Pharmacol 61 2002 800 805
4. T. Buchheit, T. Van de Ven, and A. Shaw Epigenetics and the transition from acute to chronic pain Pain Med 13 2012 1474 1490
5. T. Caspary, M.A. Cleary, C.C. Baker, X.J. Guan, and S.M. Tilghman Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster Mol Cell Biol 18 1998 3466 3474
6. X. Cheng, and R.M. Blumenthal Mammalian DNA methyltransferases: A structural perspective Structure 16 2008 341 350
7. S. Chiechio, M. Zammataro, M.E. Morales, C.L. Busceti, F. Drago, Gereau RWt, A. Copani, and F. Nicoletti Epigenetic modulation of mglu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain Mol Pharmacol 75 2009 1014 1020
8. A. Doehring, G. Geisslinger, and J. Lotsch Epigenetics in pain and analgesia: An imminent research field Eur J Pain 15 2011 11 16
9. J. Donnerer, R. Schuligoi, and C. Stein Increased content and transport of substance p and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo Neuroscience 49 1992 693 698
10. J. Dostie, Z. Mourelatos, M. Yang, A. Sharma, and G. Dreyfuss Numerous micrornps in neuronal cells containing novel micrornas RNA 9 2003 180 186
11. G.I. Elmer, J.O. Pieper, S.S. Negus, and J.H. Woods Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests Pain 75 1998 129 140
12. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
13. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded rna in caenorhabditis elegans Nature 391 1998 806 811
14. C.M. Flores, and J.S. Mogil The pharmacogenetics of analgesia: Toward a genetically-based approach to pain management Pharmacogenomics 2 2001 177 194
15. T. Fukagawa, M. Nogami, M. Yoshikawa, M. Ikeno, T. Okazaki, Y. Takami, T. Nakayama, and M. Oshimura Dicer is essential for formation of the heterochromatin structure in vertebrate cells Nat Cell Biol 6 2004 784 791
16. F. Fuks, P.J. Hurd, R. Deplus, and T. Kouzarides The DNA methyltransferases associate with hp1 and the suv39h1 histone methyltransferase Nucleic Acids Res 31 2003 2305 2312
17. S.M. Garraway, Q. Xu, and C.E. Inturrisi Design and evaluation of small interfering rnas that target expression of the n-methyl-d-aspartate receptor nr1 subunit gene in the spinal cord dorsal horn J Pharmacol Exp Ther 322 2007 982 988
18. S.M. Geranton Targeting epigenetic mechanisms for pain relief Curr Opin Pharmacol 12 2012 35 41
19. P.A. Grant, D. Schieltz, M.G. Pray-Grant, D.J. Steger, J.C. Reese, J.R. Yates 3rd, and J.L. Workman A subset of taf(ii)s are integral components of the saga complex required for nucleosome acetylation and transcriptional stimulation Cell 94 1998 45 53
20. A. Grzenda, G. Lomberk, J.S. Zhang, and R. Urrutia Sin3: Master scaffold and transcriptional corepressor Biochim Biophys Acta 1789 2009 443 450
21. W. Guo, M.T. Robbins, F. Wei, S. Zou, R. Dubner, and K. Ren Supraspinal brain-derived neurotrophic factor signaling: A novel mechanism for descending pain facilitation J Neurosci 26 2006 126 137
22. S.B. Hake, and C.D. Allis Histone h3 variants and their potential role in indexing mammalian genomes: The "H3 barcode hypothesis" Proc Natl Acad Sci U S A 103 2006 6428 6435
23. I.M. Hall, G.D. Shankaranarayana, K. Noma, N. Ayoub, A. Cohen, and S.I. Grewal Establishment and maintenance of a heterochromatin domain Science 297 2002 2232 2237
24. Y. He, C. Yang, C.M. Kirkmire, and Z.J. Wang Regulation of opioid tolerance by let-7 family microrna targeting the mu opioid receptor J Neurosci 30 2010 10251 10258
25. M.J. Hjermstad, P.M. Fayers, D.F. Haugen, A. Caraceni, G.W. Hanks, J.H. Loge, R. Fainsinger, N. Aass, and S. Kaasa Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: A systematic literature review J Pain Symptom Manage 41 2011 1073 1093
26. C.K. Hwang, X. Wu, G. Wang, C.S. Kim, and H.H. Loh Mouse mu opioid receptor distal promoter transcriptional regulation by sox proteins J Biol Chem 278 2003 3742 3750
27. C.K. Hwang, C.S. Kim, H.S. Choi, S.R. McKercher, and H.H. Loh Transcriptional regulation of mouse mu opioid receptor gene by pu.1 J Biol Chem 279 2004 19764 19774
28. C.K. Hwang, C.S. Kim, K. Kim do, P.Y. Law, L.N. Wei, and H.H. Loh Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells Mol Pharmacol 78 2010 58 68
29. C.K. Hwang, K.Y. Song, C.S. Kim, H.S. Choi, X.H. Guo, P.Y. Law, L.N. Wei, and H.H. Loh Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by mecp2 and brg1 chromatin remodelling factor J Cell Mol Med 13 2009 3591 3615
30. H.J. Im, D. Smirnov, T. Yuhi, S. Raghavan, J.E. Olsson, G.E. Muscat, P. Koopman, and H.H. Loh Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by sox18 Mol Pharmacol 59 2001 1486 1496
31. S. Istrail, and E.H. Davidson Logic functions of the genomic cis-regulatory code Proc Natl Acad Sci U S A 102 2005 4954 4959
32. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
33. C. Kanellopoulou, S.A. Muljo, A.L. Kung, S. Ganesan, R. Drapkin, T. Jenuwein, D.M. Livingston, and K. Rajewsky Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing Genes Dev 19 2005 489 501
34. T. Kanno, Y. Kanno, R.M. Siegel, M.K. Jang, M.J. Lenardo, and K. Ozato Selective recognition of acetylated histones by bromodomain proteins visualized in living cells Mol Cell 13 2004 33 43
35. A.R. Karpf, and S. Matsui Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells Cancer Res 65 2005 8635 8639
36. S. Kasama, M. Kawakubo, T. Suzuki, T. Nishizawa, A. Ishida, and J. Nakayama Rna interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat Eur J Neurosci 25 2007 2956 2963
37. B.L. Kieffer, and C.J. Evans Opioid tolerance-in search of the holy grail Cell 108 2002 587 590
38. H. Kim, D. Clark, and R.A. Dionne Genetic contributions to clinical pain and analgesia: Avoiding pitfalls in genetic research J Pain 10 2009 663 693
39. H. Kim, J.K. Neubert, A. San Miguel, K. Xu, R.K. Krishnaraju, M.J. Iadarola, D. Goldman, and R.A. Dionne Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament Pain 109 2004 488 496
40. S.S. Kim, K.K. Pandey, H.S. Choi, S.Y. Kim, P.Y. Law, L.N. Wei, and H.H. Loh Poly(c) binding protein family is a transcription factor in mu-opioid receptor gene expression Mol Pharmacol 68 2005 729 736
41. J. Kraus, C. Borner, E. Giannini, and V. Hollt The role of nuclear factor kappab in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene Mol Pharmacol 64 2003 876 884
42. G. Kustatscher, and A.G. Ladurner Modular paths to 'decoding' and 'wiping' histone lysine methylation Curr Opin Chem Biol 11 2007 628 635
43. M. Lachner, D. O'Carroll, S. Rea, K. Mechtler, and T. Jenuwein Methylation of histone h3 lysine 9 creates a binding site for hp1 proteins Nature 410 2001 116 120
44. M.L. Lacroix-Fralish, and J.S. Mogil Progress in genetic studies of pain and analgesia Annu Rev Pharmacol Toxicol 49 2009 97 121
45. M.L. LaCroix-Fralish, J.S. Austin, F.Y. Zheng, D.J. Levitin, and J.S. Mogil Patterns of pain: Meta-analysis of microarray studies of pain Pain 152 2011 1888 1898
46. P. Landgraf, M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A.O. Kamphorst, M. Landthaler, C. Lin, N.D. Socci, L. Hermida, V. Fulci, S. Chiaretti, R. Foa, J. Schliwka, U. Fuchs, A. Novosel, R.U. Muller, B. Schermer, U. Bissels, J. Inman, Q. Phan, M. Chien, D.B. Weir, R. Choksi, G. De Vita, D. Frezzetti, H.I. Trompeter, V. Hornung, G. Teng, G. Hartmann, M. Palkovits, R. Di Lauro, P. Wernet, G. Macino, C.E. Rogler, J.W. Nagle, J. Ju, F.N. Papavasiliou, T. Benzing, P. Lichter, W. Tam, M.J. Brownstein, A. Bosio, A. Borkhardt, J.J. Russo, C. Sander, M. Zavolan, and T. Tuschl A mammalian microrna expression atlas based on small rna library sequencing Cell 129 2007 1401 1414
47. G. Langst, E.J. Bonte, D.F. Corona, and P.B. Becker Nucleosome movement by chrac and iswi without disruption or trans-displacement of the histone octamer Cell 97 1999 843 852
48. P.W. Lee, and Y.M. Lee Transcriptional regulation of mu opioid receptor gene by cAMP pathway Mol Pharmacol 64 2003 1410 1418
49. G. LeRoy, G. Orphanides, W.S. Lane, and D. Reinberg Requirement of rsf and fact for transcription of chromatin templates in vitro Science 282 1998 1900 1904
50. G. Lomberk, and R. Urrutia The family feud: Turning off sp1 by sp1-like klf proteins Biochem J 392 2005 1 11
51. G. Lomberk, D. Bensi, M.E. Fernandez-Zapico, and R. Urrutia Evidence for the existence of an hp1-mediated subcode within the histone code Nat Cell Biol 8 2006 407 415
52. A. Loyola, and G. Almouzni Marking histone h3 variants: How, when and why? Trends Biochem Sci 32 2007 425 433
53. Y. Lu, J. Nie, X. Liu, Y. Zheng, and S.W. Guo Trichostatin a, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice Hum Reprod 25 2010 1014 1025
54. K. Luger, and T.J. Richmond The histone tails of the nucleosome Curr Opin Genet Dev 8 1998 140 146
55. Z. Ma, M.J. Chang, R. Shah, J. Adamski, X. Zhao, and E.N. Benveniste Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene J Biol Chem 279 2004 46326 46334
56. R. Marmorstein, and R.C. Trievel Histone modifying enzymes: Structures, mechanisms, and specificities Biochim Biophys Acta 1789 2009 58 68
57. G. Mizuguchi, X. Shen, J. Landry, W.H. Wu, S. Sen, and C. Wu Atp-driven exchange of histone h2az variant catalyzed by swr1 chromatin remodeling complex Science 303 2004 343 348
58. J.S. Mogil Pain genetics: Past, present and future Trends Genet 28 2012 258 266
59. J.S. Mogil, B. Kest, B. Sadowski, and J.K. Belknap Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: Influence of nociceptive assay J Pharmacol Exp Ther 276 1996 532 544
60. A. Muralidharan, and M.T. Smith Pain, analgesia and genetics J Pharm Pharmacol 63 2011 1387 1400
61. J. Nakayama, J.C. Rice, B.D. Strahl, C.D. Allis, and S.I. Grewal Role of histone h3 lysine 9 methylation in epigenetic control of heterochromatin assembly Science 292 2001 110 113
62. B.G. Oertel, A. Doehring, B. Roskam, M. Kettner, N. Hackmann, N. Ferreiros, P.H. Schmidt, and J. Lotsch Genetic-epigenetic interaction modulates mu-opioid receptor regulation Hum Mol Genet 21 2012 4751 4760
63. G. Orphanides, and D. Reinberg A unified theory of gene expression Cell 108 2002 439 451
64. G. Orphanides, G. LeRoy, C.H. Chang, D.S. Luse, and D. Reinberg Fact, a factor that facilitates transcript elongation through nucleosomes Cell 92 1998 105 116
65. G.I. Owen, J.K. Richer, L. Tung, G. Takimoto, and K.B. Horwitz Progesterone regulates transcription of the p21(waf1) cyclin- dependent kinase inhibitor gene through sp1 and cbp/p300 J Biol Chem 273 1998 10696 10701
66. A.H. Peters, J.E. Mermoud, D. O'Carroll, M. Pagani, D. Schweizer, N. Brockdorff, and T. Jenuwein Histone h3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin Nat Genet 30 2002 77 80
67. C.L. Peterson, and J.L. Workman Promoter targeting and chromatin remodeling by the swi/snf complex Curr Opin Genet Dev 10 2000 187 192
68. V. Rodriguez-Menendez, L. Tremolizzo, and G. Cavaletti Targeting cancer and neuropathy with histone deacetylase inhibitors: Two birds with one stone? Curr Cancer Drug Targets 8 2008 266 274
69. P. Sahbaie, X. Shi, T.Z. Guo, Y. Qiao, D.C. Yeomans, W.S. Kingery, and J.D. Clark Role of substance p signaling in enhanced nociceptive sensitization and local cytokine production after incision Pain 145 2009 341 349
70. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
71. K.T. Sibille, L. Witek-Janusek, H.L. Mathews, and R.B. Fillingim Telomeres and epigenetics: Potential relevance to chronic pain Pain 153 2012 1789 1793
72. A. Smallwood, P.O. Esteve, S. Pradhan, and M. Carey Functional cooperation between hp1 and dnmt1 mediates gene silencing Genes Dev 21 2007 1169 1178
73. B.C. Smith, and J.M. Denu Chemical mechanisms of histone lysine and arginine modifications Biochim Biophys Acta 1789 2009 45 57
74. M.T. Smith, and A. Muralidharan Pharmacogenetics of pain and analgesia Clin Genet 82 2012 321 330
75. A.A. Somogyi, D.T. Barratt, and J.K. Coller Pharmacogenetics of opioids Clin Pharmacol Ther 81 2007 429 444
76. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
77. P. Sudarsanam, and F. Winston The swi/snf family nucleosome-remodeling complexes and transcriptional control Trends Genet 16 2000 345 351
78. M. Szyf Epigenetics, DNA methylation, and chromatin modifying drugs Annu Rev Pharmacol Toxicol 49 2009 243 263
79. P.H. Tan, L.C. Yang, H.C. Shih, K.C. Lan, and J.T. Cheng Gene knockdown with intrathecal sirna of nmda receptor nr2b subunit reduces formalin-induced nociception in the rat Gene Ther 12 2005 59 66
80. P.R. Thompson, H. Kurooka, Y. Nakatani, and P.A. Cole Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity J Biol Chem 276 2001 33721 33729
81. J. Tremblay, and P. Hamet Genetics of pain, opioids, and opioid responsiveness Metabolism 59 Suppl 1 2010 S5 S8
82. T. Tsukiyama, J. Palmer, C.C. Landel, J. Shiloach, and C. Wu Characterization of the imitation switch subfamily of atp-dependent chromatin-remodeling factors in saccharomyces cerevisiae Genes Dev 13 1999 686 697
83. T.A. Volpe, C. Kidner, I.M. Hall, G. Teng, S.I. Grewal, and R.A. Martienssen Regulation of heterochromatic silencing and histone h3 lysine-9 methylation by rnai Science 297 2002 1833 1837
84. Y. Wang, W. Fischle, W. Cheung, S. Jacobs, S. Khorasanizadeh, and C.D. Allis Beyond the double helix: Writing and reading the histone code Novartis Found Symp 259 2004 3 17 discussion 17-21, 163-169
85. L.N. Wei, and H.H. Loh Transcriptional, epigenetic regulation of opioid receptor genes: Present and future Annu Rev Pharmacol Toxicol 51 2011 75 97
86. C.J. Woolf, B. Safieh-Garabedian, Q.P. Ma, P. Crilly, and J. Winter Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity Neuroscience 62 1994 327 331
87. Q. Wu, P.Y. Law, L.N. Wei, and H.H. Loh Post-transcriptional regulation of mouse mu opioid receptor (mor1) via its 3' untranslated region: A role for microrna23b FASEB J 22 2008 4085 4095
88. Y. Xue, J. Wong, G.T. Moreno, M.K. Young, J. Cote, and W. Wang Nurd, a novel complex with both atp-dependent chromatin-remodeling and histone deacetylase activities Mol Cell 2 1998 851 861
89. J.K. Zubieta, M.M. Heitzeg, Y.R. Smith, J.A. Bueller, K. Xu, Y. Xu, R.A. Koeppe, C.S. Stohler, and D. Goldman Comt val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor Science 299 2003 1240 1243